A Novel Weizmannia coagulans Strain WC412 with Superior Environmental Resilience Improves Growth Performance of Mice by Regulating the Intestinal Microbiota

The growing demand for sustainable and antibiotic-free animal production has intensified interest in probiotics as functional feed additives. In this study, novel strains of Weizmannia coagulans (WC412 and WC413) were isolated from pickle water—a previously unexplored source for probiotic screening. These isolates, along with three reference strains (W. coagulans S8, S15, and S17), were evaluated for their tolerance to heat, acid, and bile salts. Strain WC412 exhibited superior environmental resilience, as validated by principal component analysis (PCA) for comprehensive stress-tolerance assessment, and was selected for further investigations. A murine model was employed to assess the physiological and microbiological impacts of WC412 supplementation at varying doses. Medium-dose (1 × 107 CFU·mL−1) administration significantly improved body weight gain by 13% (p < 0.05), modulated serum lipid profiles, and increased antioxidant enzyme activity and IgG/IL-2 levels (p < 0.05). Notably, WC412 uniquely enriched beneficial genera (e.g., Fructilactobacillus and Limosilactobacillus) and promoted metabolic pathways linked to short-chain fatty acid production, as revealed by 16S rDNA sequencing and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. These findings highlight WC412 as a robust probiotic candidate for enhancing animal growth performance and gut health through novel microbiota-mediated mechanisms.